Related Experiment Videos

Maternal mortality in India: current status and strategies for reduction

A Prakash¹, S Swain, A Seth

¹Department of Obstetrics and Gynecology, Institute of Medical Sciences, Banaras Hindu University, Varanasi.

Indian Pediatrics

|December 1, 1991

Abstract

No abstract available in PubMed .

Keywords:

Abortion, Illegal Abortion, Induced Academic Training Age Factors Asia Bleeding Community Health Services Critique Delivery Of Health Care Demographic Factors Developing Countries Diseases Economic Factors Education Family Planning Family Planning Programs Fertility Fertility Control, Postconception Fertility Measurements Health Health Education--women Health Services Health Services Evaluation Human Rights India Infections Integrated Programs Maternal Health Maternal Mortality Maternal-child Health Services Mortality Mortality Determinants Multiparity Organization And Administration Parity Population Population Characteristics Population Dynamics Pregnancy, Unplanned Primary Health Care Program Evaluation Programs Quality Of Health Care Reproductive Behavior Reproductive Health Rural Population Sex Education Signs And Symptoms Socioeconomic Factors Southern Asia Training Programs Transportation

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Search for the Decay B^{+}→K^{+}τ^{+}τ^{-} Using Data from the Belle and Belle II Experiments.

Physical review letters·2026

Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status.

ESMO gastrointestinal oncology·2026

Search for B^{0}→K^{*0}τ^{+}τ^{-} Decays at the Belle II Experiment.

Physical review letters·2025

Search for a Dark Higgs Boson Produced in Association with Inelastic Dark Matter at the Belle II Experiment.

Physical review letters·2025

Uncovering PD-L1 among immune cell predictive biomarkers and actionable genetic alterations in anal squamous-cell carcinomas in the era of immunotherapy.

ESMO open·2025

NK cell line modified to express a potent, DR5 specific variant of TRAIL, show enhanced cytotoxicity in ovarian cancer models.

Heliyon·2024

See all related articles